ICU MEDICAL INC/DE Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Icu Medical Inc/De quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2011 to Q2 2024.
  • Icu Medical Inc/De Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$21.4M, a 115% decline year-over-year.
  • Icu Medical Inc/De Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$70.8M, a 46% decline year-over-year.
  • Icu Medical Inc/De annual Net Income (Loss) Attributable to Parent for 2023 was -$29.7M, a 60.1% increase from 2022.
  • Icu Medical Inc/De annual Net Income (Loss) Attributable to Parent for 2022 was -$74.3M, a 172% decline from 2021.
  • Icu Medical Inc/De annual Net Income (Loss) Attributable to Parent for 2021 was $103M, a 18.7% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$70.8M -$21.4M -$11.5M -115% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$59.3M -$39.5M -$29.7M -302% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-07
Q4 2023 -$29.7M $29.6M +$48.5M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$78.1M -$39.5M -$29.7M -302% Jul 1, 2023 Sep 30, 2023 10-Q 2024-05-07
Q2 2023 -$48.5M -$9.93M -$2.46M -32.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$46M -$9.81M +$28.3M +74.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-07
Q4 2022 -$74.3M -$18.9M -$38.9M -195% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$35.4M -$9.81M -$40.9M -132% Jul 1, 2022 Sep 30, 2022 10-Q 2024-05-07
Q2 2022 $5.46M -$7.47M -$35.9M -126% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-06
Q1 2022 $41.3M -$38.1M -$61.8M -260% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-06
Q4 2021 $103M $19.9M -$6.22M -23.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $109M $31.1M +$6.1M +24.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $103M $28.4M +$9.49M +50.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-07
Q1 2021 $93.8M $23.7M +$6.9M +41% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-07
Q4 2020 $86.9M $26.1M +$5.5M +26.7% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-26
Q3 2020 $81.4M $25M -$1.58M -5.94% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $82.9M $18.9M -$3.93M -17.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-05
Q1 2020 $86.9M $16.8M -$14.2M -45.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-05
Q4 2019 $101M $20.6M +$28M Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 $73M $26.6M +$26.3M +12029% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-26
Q2 2019 $46.7M $22.8M -$8.22M -26.5% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-26
Q1 2019 $54.9M $31M +$26.1M +536% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-26
Q4 2018 $28.8M -$7.36M -$57.1M -115% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 $85.9M $219K +$83K +61% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 $85.8M $31.1M +$68.1M Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 $17.7M $4.88M -$51M -91.3% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 $68.6M $49.7M +$40.2M +423% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 $28.5M $136K -$18.7M -99.3% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 $47.1M -$37.1M -$53.7M -323% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 $101M $55.9M +$37.7M +208% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 $63.1M $9.51M +$4.05M +74.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 $59M $18.8M +$2.54M +15.6% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 $56.5M $16.6M +$3.04M +22.4% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 $53.5M $18.2M +$8.47M +87.5% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 $45M $5.46M -$1.91M -25.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-01
Q3 2015 $46.9M $16.3M +$9.84M +153% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-01
Q2 2015 $37.1M $13.6M +$7.69M +131% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-01
Q1 2015 $29.4M $9.69M +$3.03M +45.5% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-01
Q4 2014 $26.3M $7.37M -$5.96M -44.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-26
Q3 2014 $32.3M $6.43M -$4.61M -41.7% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-26
Q2 2014 $36.9M $5.88M -$1.49M -20.2% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-26
Q1 2014 $38.4M $6.66M -$2.03M -23.4% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-26
Q4 2013 $40.4M $13.3M +$989K +8.01% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-20
Q3 2013 $39.4M $11M -$1.15M -9.47% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-20
Q2 2013 $40.6M $7.37M -$1.78M -19.5% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-20
Q1 2013 $42.4M $8.69M +$1.08M +14.3% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-20
Q4 2012 $41.3M $12.3M -$5.5M -30.8% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-21
Q3 2012 $46.8M $12.2M +$2.93M +31.6% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-21
Q2 2012 $43.9M $9.15M -$344K -3.62% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-21
Q1 2012 $44.2M $7.6M -$472K -5.85% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-21
Q4 2011 $44.7M $17.8M Oct 1, 2011 Dec 31, 2011 10-K 2013-02-26
Q3 2011 $9.26M Jul 1, 2011 Sep 30, 2011 10-K 2013-02-26
Q2 2011 $9.49M Apr 1, 2011 Jun 30, 2011 10-K 2013-02-26
Q1 2011 $8.07M Jan 1, 2011 Mar 31, 2011 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.